RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xiangxue Pharmaceutical Co Stock

Xiangxue Pharmaceutical Co P/S 2024

Xiangxue Pharmaceutical Co P/S

1.61

Ticker

300147.SZ

ISIN

CNE100000Y92

As of Aug 26, 2024, Xiangxue Pharmaceutical Co's P/S ratio stood at 1.61, a -2.42% change from the 1.65 P/S ratio recorded in the previous year.

The Xiangxue Pharmaceutical Co P/S history

Xiangxue Pharmaceutical Co Aktienanalyse

What does Xiangxue Pharmaceutical Co do?

Xiangxue Pharmaceutical Co Ltd is one of the leading companies in the field of traditional Chinese medicine. The company was founded in 1994 and has since undergone impressive development. Originally started as a small company, Xiangxue now has a market share of 10% and is listed on the stock exchange. The company's business model is based on the manufacturing and sale of traditional Chinese medicines. Various herbs and plants are processed into powders, tablets, or liquids and offered in the form of medicines. The application of the products follows the principles of Chinese medicine, which aim to restore the balance between yin and yang in the body. Xiangxue is divided into different divisions to meet the various needs of customers. The largest division is basic care, which focuses on general health care and offers products such as dietary supplements, enzyme preparations, and vitamins. The second division deals with the treatment of digestive system disorders. Here, Xiangxue offers a wide range of products, ranging from the prevention of gastrointestinal complaints to the treatment of conditions such as gastritis and colitis. The third division covers the treatment of respiratory system disorders such as asthma and chronic bronchitis. The company also offers a variety of products in this area, allowing for a broad range of applications. Additionally, there is a division that specializes in the treatment of colds and flu. One of Xiangxue's most famous products is "Shexiang Zhuifeng Gao," a pain-relieving patch. The product has been popular in China and other Asian countries for many years and has also gained international recognition. It is an effective pain relief product that can be used in the treatment of joint pain, back pain, and other pain conditions. In addition to its medicines, Xiangxue also conducts research and development to improve its production processes and active ingredients. The company has a strong research department that focuses on Chinese medicine and collaborates closely with academic institutions and research facilities. Overall, Xiangxue has a strong focus on quality and innovation. The company strives to provide its customers with high-quality products based on traditional Chinese healing methods while also delivering scientific performance. The company is able to meet the high standards of the pharmaceutical industry while maintaining its deep roots in Chinese medicine. Xiangxue understands the needs of its customers and has developed a successful strategy to provide them with the best possible healthcare. The company is an important player in the industry and has earned the respect and loyalty of its customers. Xiangxue Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Xiangxue Pharmaceutical Co's P/S Ratio

Xiangxue Pharmaceutical Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Xiangxue Pharmaceutical Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Xiangxue Pharmaceutical Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Xiangxue Pharmaceutical Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Xiangxue Pharmaceutical Co stock

What is the price-to-earnings ratio of Xiangxue Pharmaceutical Co?

The price-earnings ratio of Xiangxue Pharmaceutical Co is currently 1.61.

How has the price-earnings ratio of Xiangxue Pharmaceutical Co changed compared to last year?

The price-to-earnings ratio of Xiangxue Pharmaceutical Co has increased by -2.42% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Xiangxue Pharmaceutical Co high compared to other companies?

Yes, the price-to-earnings ratio of Xiangxue Pharmaceutical Co is high compared to other companies.

How does an increase in the price-earnings ratio of Xiangxue Pharmaceutical Co affect the company?

An increase in the price-earnings ratio of Xiangxue Pharmaceutical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Xiangxue Pharmaceutical Co affect the company?

A decrease in the price-earnings ratio of Xiangxue Pharmaceutical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Xiangxue Pharmaceutical Co?

Some factors that influence the price-earnings ratio of Xiangxue Pharmaceutical Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Xiangxue Pharmaceutical Co pay?

Over the past 12 months, Xiangxue Pharmaceutical Co paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 0.56 %. For the coming 12 months, Xiangxue Pharmaceutical Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Xiangxue Pharmaceutical Co?

The current dividend yield of Xiangxue Pharmaceutical Co is 0.56 %.

When does Xiangxue Pharmaceutical Co pay dividends?

Xiangxue Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, September, July.

How secure is the dividend of Xiangxue Pharmaceutical Co?

Xiangxue Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Xiangxue Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xiangxue Pharmaceutical Co located?

Xiangxue Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xiangxue Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xiangxue Pharmaceutical Co from 6/23/2020 amounting to 0.046 CNY, you needed to have the stock in your portfolio before the ex-date on 6/23/2020.

When did Xiangxue Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/23/2020.

What was the dividend of Xiangxue Pharmaceutical Co in the year 2023?

In the year 2023, Xiangxue Pharmaceutical Co distributed 0 CNY as dividends.

In which currency does Xiangxue Pharmaceutical Co pay out the dividend?

The dividends of Xiangxue Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xiangxue Pharmaceutical Co

Our stock analysis for Xiangxue Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xiangxue Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.